Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study
Open Access
- 31 January 2021
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 106 (2), 622-625
- https://doi.org/10.3324/haematol.2020.250522
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunityExpert Review of Hematology, 2017
- New Insights in the Pathogenesis of Autoimmune Hemolytic AnemiaTransfusion Medicine and Hemotherapy, 2015
- Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patientsBlood, 2014
- Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrolleesThrombosis Research, 2014
- The Effect of Erythropoiesis-Stimulating Agents in Patients with Therapy-Refractory Autoimmune Hemolytic AnemiaTransfusion Medicine and Hemotherapy, 2014
- Erythropoietin May Improve Anemia in Patients with Autoimmune Hemolytic Anemia Associated with ReticulocytopeniaTransfusion Medicine and Hemotherapy, 2012
- Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesBlood, 2012
- New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 childrenHaematologica, 2011
- Anemia of chronic disease and defective erythropoietin production in patients with celiac diseaseHaematologica, 2008
- Circulating thrombopoietin level in chronic immune thrombocytopenic purpuraBritish Journal of Haematology, 1996